[Research progress in systemic lupus erythematosus from 2021 to 2022]. / 20212022年度系ç»æ§çº¢æç¼ç®ç 究è¿å±çç¹.
Zhongguo Dang Dai Er Ke Za Zhi
; 25(8): 785-790, 2023 Aug 15.
Article
em Zh
| MEDLINE
| ID: mdl-37668024
ABSTRACT
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems, presenting a complex and diverse clinical manifestation. The heterogeneous treatment response and prognosis of SLE pose significant challenges to its diagnosis, classification, and homogeneous treatment. The emergence of new technologies and fields, such as synthetic biology, genomics, and proteomics, has contributed to a deeper exploration of the pathogenesis and biomarkers of SLE, facilitating precision diagnosis and treatment. This review summarizes the latest research data and achievements in SLE for the years 2021-2022, providing an overview and summary of relevant studies conducted in the past two years.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Lúpus Eritematoso Sistêmico
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
Zh
Revista:
Zhongguo Dang Dai Er Ke Za Zhi
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China